Interactions between Xenobiotics and DME (XEOTIC)
|
Amino Acid(s), Peptide(s) or Protein(s) |
Peptide |
Click to Show/Hide the Full List of Xenobiotics: 9 Xenobiotics
|
Beta-defensin BD-8 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO02443
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
Beta-defensin BD-8 inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia |
[1] |
CTX-1 peptide NCP-3a |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO04241
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
CTX-1 peptide NCP-3a inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia |
[2] |
CTX-1 peptide NCP-3b |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO04242
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
CTX-1 peptide NCP-3b inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia |
[2] |
Dermatoxin |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO03164
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
Dermatoxin inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia |
[3] |
Hydramacin Hm-1 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO03609
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
Hydramacin Hm-1 inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia |
[4], [5] |
Murine beta-defensin related peptide Defr1 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO03127
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
Murine beta-defensin related peptide Defr1 inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia |
[6] |
NCP-0 peptide |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO04240
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
NCP-0 peptide inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia |
[2] |
Piscidin Pis-1 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO04612
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
Piscidin Pis-1 inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia (MIC > 20 microM) |
[7] |
Piscidin Pis-2 |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO04613
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Peptide |
DME Modulation |
Piscidin Pis-2 inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia (MIC > 20 microM) |
[8] |
Pharmaceutical Agent(s) |
Approved/Marketed Drug |
Click to Show/Hide the Full List of Xenobiotics: 3 Xenobiotics
|
Copper sulfate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00117
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Approved by US FDA |
DME Modulation |
Copper sulfate inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia |
[9] |
Silver nitrate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00511
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Marketed but not Approved by US FDA |
DME Modulation |
Silver nitrate inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia |
[9] |
Zinc sulfate |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO00460
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Drug Marketed but not Approved by US FDA |
DME Modulation |
Zinc sulfate inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia |
[9] |
Investigative Agent |
Click to Show/Hide the Full List of Xenobiotics: 1 Xenobiotics
|
Carboxymethyl chitosan |
Click to Show/Hide the Detail |
Inhibition |
XEOTIC ID |
XEO02714
XEOTIC Info
|
Gene Form |
Protein |
Classification |
Investigative Agent |
DME Modulation |
Carboxymethyl chitosan inhibits the drug-metabolizing activity of PenA beta-lactamase (penA1) from Burkholderia cepacia |
[9] |
|
|
|
|
|
|